Page last updated: 2024-11-06

iomeglamic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

iomeglamic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65721
CHEMBL ID2104342
CHEBI ID135850
SCHEMBL ID668414
MeSH IDM0042522

Synonyms (34)

Synonym
acido iomeglamico [spanish]
n-methyl-n-(2,4,6-trijod-3-aminophenyl)-glutaramidsaeure [german]
iomeglamis acid
iomeglamsaeure [german]
glutaranilic acid, 3'-amino-n-methyl-2',4',6'-triiodo-
n-methyl-n-(2,4,6-triiodo-3-aminophenyl)glutaramidic acid
falignost
3'-amino-2',4',6'-triiodo-n-methylglutaranilic acid
acidum iomeglamicum [latin]
5-((3-amino-2,4,6-triiodophenyl)methylamino)-5-oxopentanoic acid
pentanoic acid, 5-((3-amino-2,4,6-triiodophenyl)methylamino)-5-oxo-
iomeglamic acid [inn]
brn 2820296
acide iomeglamique [french]
iomeglamic acid
rg 270
n-methyl-n-(3-amino-2,4,6-triiodophenyl)glutaramic acid
CHEBI:135850
5-(3-amino-2,4,6-triiodo-n-methylanilino)-5-oxopentanoic acid
iomeglamsaeure
unii-s4h62451to
acido iomeglamico
25827-76-3
acidum iomeglamicum
n-methyl-n-(2,4,6-trijod-3-aminophenyl)-glutaramidsaeure
s4h62451to ,
acide iomeglamique
CHEMBL2104342
rg-270
iomeglamic acid [mi]
iomeglamic acid [who-dd]
SCHEMBL668414
DTXSID30180480
Q27288580
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
anilideAny aromatic amide obtained by acylation of aniline.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.51 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]